Ernexa Therapeutics ERNA
NASDAQ ERNA
$4.83 +0.22 (+4.66%)
As of: Aug 21, 2026 · 12:07 PM EDT

Ernexa Therapeutics Inc. (ERNA) FCF Payout Ratio (2010 - 2015)

Ernexa Therapeutics' (ERNA) quarterly FCF Payout Ratio came in at 0.0 in Q4 2015, down 150.12% YoY from 0.01 in Q4 2014, and down 150.12% on a QoQ basis from 0.01 in Q4 2014.

Ernexa Therapeutics Inc. (ERNA) FCF Payout Ratio (2010 - 2015) Analysis & Trends

Ernexa Therapeutics (ERNA) has 4 years of FCF Payout Ratio data on file, last reported at 0.0 in Q4 2015.

  • Quarterly FCF Payout Ratio fell 150.12% year-over-year to 0.0 in Q4 2015, while the trailing twelve-month figure through Sep 2019 was 0.01 (down 83.89% YoY) and the FY2015 annual result came in at 0.0, down 241.19% from the prior year.
  • FCF Payout Ratio slipped to 0.0 in Q4 2015, from 0.01 in the prior quarter.
  • In the past five years, FCF Payout Ratio ranged from a high of 0.01 in Q4 2014 to a low of 0.02 in Q4 2011.
  • A 3-year average of 0.0 and a median of 0.0 in 2015 frame the typical range for FCF Payout Ratio.
  • Annual changes were most pronounced in 2011 — FCF Payout Ratio sank 102.68% — and 2015, when it tumbled 150.12%.
  • Tracing ERNA's FCF Payout Ratio over 3 years: stood at 0.02 in 2011, then soared by 141.16% to 0.01 in 2014, then sank by 150.12% to 0.0 in 2015.
  • The last three FCF Payout Ratio figures came in at 0.0 (Q4 2015), 0.01 (Q4 2014), and 0.02 (Q4 2011), per Business Quant data.

Peer Comparison

Historic Data

Download Data
DateValue
Dec 31, 2015 0.00
Dec 31, 2014 0.01
Dec 31, 2011 -0.02
Dec 31, 2010 0.67